Concepedia

Britta Besemer

BB

Statistics

Publications

42

Citations

3K

H-Index

22

Active since

2010

Affiliations

Universität Hamburg(Current)

University Medical Center Hamburg-Eppendorf

Heidelberg University

University of Tübingen

University Hospital Heidelberg

Britta Besemer is an author at Universität Hamburg specializing in multiple myeloma, multiple myeloma therapy, and multiple myeloma treatment.

Publications per year

2010–2025

42

Publications

42

Teclistamab in Relapsed or Refractory Multiple Myeloma

Philippe Moreau, Alfred L. Garfall, Niels W.C.J. van de Donk et al. · New England Journal of Medicine · 2022 · 1.1K citations · Full text

, , +17

Daratumumab plus pomalidomide and dexamethasone versus pomalidomide and dexamethasone alone in previously treated multiple myeloma (APOLLO): an open-label, randomised, phase 3 trial

Meletios Α. Dimopoulos, Evangelos Terpos, Mario Boccadoro et al. · The Lancet Oncology · 2021 · 327 citations

, , +14

Isatuximab, Bortezomib, Lenalidomide, and Dexamethasone for Multiple Myeloma

Thierry Façon, Meletios Α. Dimopoulos, Xavier P Leleu et al. · New England Journal of Medicine · 2024 · 243 citations

, , +16

Isatuximab, Carfilzomib, Lenalidomide, and Dexamethasone for the Treatment of High-Risk Newly Diagnosed Multiple Myeloma

Lisa Leypoldt, Diana Tichy, Britta Besemer et al. · Journal of Clinical Oncology · 2023 · 141 citations · Full text

, , +17

Real-world analysis of teclistamab in 123 RRMM patients from Germany

Christine Riedhammer, Florian Bassermann, Britta Besemer et al. · Leukemia · 2024 · 104 citations · Full text

, , +2

1–5 of 42